Clinical Trial Dosing
![Initiation of Treatment with TTI-101, Either Alone or in Combination with Standard Targeted Therapy, in Advanced Hepatocellular Carcinoma _ Pharmtales - Latest Pharma News & Insights](https://pharmtales.com/wp-content/uploads/2023/06/Initiation-of-Treatment-with-TTI-101-Either-Alone-or-in-Combination-with-Standard-Targeted-Therapy-in-Advanced-Hepatocellular-Carcinoma-_-Pharmtales-Latest-Pharma-News-Insights.jpg)
Initiation of Treatment with TTI-101, Either Alone or in Combination with Standard Targeted Therapy, in Advanced Hepatocellular Carcinoma
SG Tylor
Source – Tvardi Therapeutics On June 22, 2023 the initial administration of TTI-101, either as a monotherapy or in combination ...